Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine Piccart

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Clinical Breast Cancer|September 10, 2008
Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancerMartine Piccart
Breast Cancer Research and Treatment|July 19, 2003
The role of taxanes in the adjuvant treatment of early stage breast cancerMartine Piccart
Annual Review of Medicine|November 12, 2014
Neoadjuvant therapy for breast cancerDimitrios Zardavas, Martine Piccart
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast CancerDimitrios Zardavas, Martine Piccart-Gebhart
Oncology|November 8, 2002
Moving forward: Herceptin in the adjuvant settingElizabeth Tan-Chiu, Martine Piccart
Cancer Biology & Medicine|July 27, 2016
New generation of breast cancer clinical trials implementing molecular profilingDimitrios Zardavas, Martine Piccart-Gebhart
Bulletin Du Cancer|March 1, 2003
[News in the medical treatment of breast cancer]Martine Piccart, Emmanuelle Dochy, Fatima Cardoso
Critical Reviews in Oncology/Hematology|November 8, 2006
The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen responseSherene Loi, Martine Piccart, Christos Sotiriou
Future Oncology (London, England)|August 2, 2013
Personalized therapy for breast cancer: a dream or a reality?Dimitrios Zardavas, Lina Pugliano, Martine Piccart
Current Treatment Options in Oncology|April 2, 2019
Antibody-Drug Conjugates in Breast Cancer: a Comprehensive ReviewNoam Pondé, Philippe Aftimos, Martine Piccart
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Clinical Breast Cancer|September 10, 2008
Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancerMartine Piccart
Breast Cancer Research and Treatment|July 19, 2003
The role of taxanes in the adjuvant treatment of early stage breast cancerMartine Piccart
Annual Review of Medicine|November 12, 2014
Neoadjuvant therapy for breast cancerDimitrios Zardavas, Martine Piccart
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast CancerDimitrios Zardavas, Martine Piccart-Gebhart
Oncology|November 8, 2002
Moving forward: Herceptin in the adjuvant settingElizabeth Tan-Chiu, Martine Piccart
Cancer Biology & Medicine|July 27, 2016
New generation of breast cancer clinical trials implementing molecular profilingDimitrios Zardavas, Martine Piccart-Gebhart
Bulletin Du Cancer|March 1, 2003
[News in the medical treatment of breast cancer]Martine Piccart, Emmanuelle Dochy, Fatima Cardoso
Critical Reviews in Oncology/Hematology|November 8, 2006
The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen responseSherene Loi, Martine Piccart, Christos Sotiriou
Future Oncology (London, England)|August 2, 2013
Personalized therapy for breast cancer: a dream or a reality?Dimitrios Zardavas, Lina Pugliano, Martine Piccart
Current Treatment Options in Oncology|April 2, 2019
Antibody-Drug Conjugates in Breast Cancer: a Comprehensive ReviewNoam Pondé, Philippe Aftimos, Martine Piccart
Pageof 32